BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22104271)

  • 1. Expression of hypoxia-inducible factor 1α predicts clinical outcome after preoperative hyperthermo-chemoradiotherapy for locally advanced rectal cancer.
    Shioya M; Takahashi T; Ishikawa H; Sakurai H; Ebara T; Suzuki Y; Saitoh J; Ohno T; Asao T; Kuwano H; Nakano T
    J Radiat Res; 2011; 52(6):821-7. PubMed ID: 22104271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hypoxia-inducible factor-1α and CD133 predicts pathological complete response and survival for locally advanced rectal cancer patients after neoadjuvant chemoradiotherapy].
    Cai C; Wang J; Zhong Z; Dai Z; Wang Q; Dong W; Shi H; Liu Q; DU J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 Jan; 46(1):36-43. PubMed ID: 28436629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of immunohistochemical expression of hypoxia-inducible factor-1alpha as a prognostic marker in rectal adenocarcinoma.
    Lu XG; Xing CG; Feng YZ; Chen J; Deng C
    Clin Colorectal Cancer; 2006 Jan; 5(5):350-3. PubMed ID: 16512994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of CD133 and hypoxia inducible factor-1α gene expression in rectal cancer after preoperative chemoradiotherapy.
    Saigusa S; Tanaka K; Toiyama Y; Yokoe T; Okugawa Y; Koike Y; Fujikawa H; Inoue Y; Miki C; Kusunoki M
    Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):323-32. PubMed ID: 20970309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative radiotherapy downregulates the nuclear expression of hypoxia-inducible factor-1alpha in rectal cancer.
    Korkeila E; Jaakkola PM; Syrjänen K; Sundström J; Pyrhönen S
    Scand J Gastroenterol; 2010 Mar; 45(3):340-8. PubMed ID: 20001759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose transporter 1 (GLUT1) of anaerobic glycolysis as predictive and prognostic values in neoadjuvant chemoradiotherapy and laparoscopic surgery for locally advanced rectal cancer.
    Shim BY; Jung JH; Lee KM; Kim HJ; Hong SH; Kim SH; Sun DS; Cho HM
    Int J Colorectal Dis; 2013 Mar; 28(3):375-83. PubMed ID: 22847606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-inducible factor-1alpha and -2alpha are expressed in most rectal cancers but only hypoxia-inducible factor-1alpha is associated with prognosis.
    Rasheed S; Harris AL; Tekkis PP; Turley H; Silver A; McDonald PJ; Talbot IC; Glynne-Jones R; Northover JM; Guenther T
    Br J Cancer; 2009 May; 100(10):1666-73. PubMed ID: 19436307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA class I expression and its alteration by preoperative hyperthermo-chemoradiotherapy in patients with rectal cancer.
    Sato H; Suzuki Y; Ide M; Katoh T; Noda SE; Ando K; Oike T; Yoshimoto Y; Okonogi N; Mimura K; Asao T; Kuwano H; Nakano T
    PLoS One; 2014; 9(9):e108122. PubMed ID: 25259797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of long interval between hyperthermochemoradiation therapy and surgery for rectal cancer on apoptosis, proliferation and tumor response.
    Kato T; Fujii T; Ide M; Takada T; Sutoh T; Morita H; Yajima R; Yamaguchi S; Tsutsumi S; Asao T; Oyama T; Kuwano H
    Anticancer Res; 2014 Jun; 34(6):3141-6. PubMed ID: 24922685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIF-1alpha is an unfavorable determinant of relapse in gastric cancer patients who underwent curative surgery followed by adjuvant 5-FU chemotherapy.
    Nakamura J; Kitajima Y; Kai K; Hashiguchi K; Hiraki M; Noshiro H; Miyazaki K
    Int J Cancer; 2010 Sep; 127(5):1158-71. PubMed ID: 20020496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selecting patients for hyperthermia combined with preoperative chemoradiotherapy for locally advanced rectal cancer.
    Kim SW; Yea JW; Kim JH; Gu MJ; Kang MK
    Int J Clin Oncol; 2018 Apr; 23(2):287-297. PubMed ID: 29134362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiles of epidermal growth factor receptor, vascular endothelial growth factor and hypoxia-inducible factor-1 with special reference to local responsiveness to neoadjuvant chemoradiotherapy and disease recurrence after rectal cancer surgery.
    Toiyama Y; Inoue Y; Saigusa S; Okugawa Y; Yokoe T; Tanaka K; Miki C; Kusunoki M
    Clin Oncol (R Coll Radiol); 2010 May; 22(4):272-80. PubMed ID: 20117921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of stromal cell-derived factor 1α expression is associated with the resistance to neoadjuvant chemoradiotherapy of locally advanced rectal cancer: angiogenic markers of neoadjuvant chemoradiation.
    Kim HJ; Bae SB; Jeong D; Kim ES; Kim CN; Park DG; Ahn TS; Cho SW; Shin EJ; Lee MS; Baek MJ
    Oncol Rep; 2014 Dec; 32(6):2493-500. PubMed ID: 25241658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymidine phosphorylase and hypoxia-inducible factor 1-α expression in clinical stage II/III rectal cancer: association with response to neoadjuvant chemoradiation therapy and prognosis.
    Lin S; Lai H; Qin Y; Chen J; Lin Y
    Int J Clin Exp Pathol; 2015; 8(9):10680-8. PubMed ID: 26617778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-type amino-acid transporter 1 expression predicts the response to preoperative hyperthermo-chemoradiotherapy for advanced rectal cancer.
    Ebara T; Kaira K; Saito J; Shioya M; Asao T; Takahashi T; Sakurai H; Kanai Y; Kuwano H; Nakano T
    Anticancer Res; 2010 Oct; 30(10):4223-7. PubMed ID: 21036745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of hypoxia-inducible factor-1 alpha and prolyl 4-hydroxylase beta polypeptide overexpression in gastric cancer.
    Zhang J; Wu Y; Lin YH; Guo S; Ning PF; Zheng ZC; Wang Y; Zhao Y
    World J Gastroenterol; 2018 Jun; 24(22):2381-2391. PubMed ID: 29904245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-related proteins in patients with rectal cancer undergoing neoadjuvant combined modality therapy.
    Lee-Kong SA; Ruby JA; Chessin DB; Pucciarelli S; Shia J; Riedel ER; Nitti D; Guillem JG
    Dis Colon Rectum; 2012 Sep; 55(9):990-5. PubMed ID: 22874607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment HIF-1α and GLUT-1 expressions do not correlate with outcome after preoperative chemoradiotherapy in rectal cancer.
    Havelund BM; Sørensen FB; Lindebjerg J; Spindler KL; Jakobsen A
    Anticancer Res; 2011 May; 31(5):1559-65. PubMed ID: 21617210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of the expression of vascular endothelial growth factor A and hypoxia-inducible factor 1alpha in patients undergoing surgery for non-small cell lung cancer].
    Honguero Martínez AF; Arnau Obrer A; Figueroa Almazán S; Martínez Hernández N; Guijarro Jorge R
    Med Clin (Barc); 2014 May; 142(10):432-7. PubMed ID: 23948151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of preoperative radiotherapy or chemoradiotherapy in sphincter preservation for locally advanced middle-low rectal cancer].
    Cao WG; Zhao R; Xi WQ; Ma T; Li H; Xu HP; Che JF; Jin YN
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):225-7. PubMed ID: 17649643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.